Pharma News
What Novo Nordisk’s Purchase of Catalent Means for the Industry
Bruce Phelan of Blue Fin discusses pharma’s need for access to manufacturing sites.
Source link
#Novo #Nordisks #Purchase #Catalent #Means #Industry
Bruce Phelan of Blue Fin discusses pharma’s need for access to manufacturing sites.
Source link
#Novo #Nordisks #Purchase #Catalent #Means #Industry
MEEFRO